NCT07351318
Estimating Insulin Sensitivity in Pregnancies With Type 1 Diabetes
Enrolling by Invitation
Not specifiedAges 18+ObservationalUniversity of VirginiaInvestigator-initiated
~100 participants
Updated 2026-03-02 on ClinicalTrials.gov
At a glance
Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Percent Time in Target Range
Measured over Assessed every 2 weeks from 4 weeks pre-conception to 6 months post partum
Conditions
Where it's being run
2 sites across 2 statesIllinois1
Virginia1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Age \>=18 years old
Pregnant within the last 8 years
Diagnosed with type 1 diabetes for at least one year at the time of pregnancy
Use of a Dexcom CGM system (Dexcom, Inc., CA) and Tandem insulin infusion pump (Tandem Diabetes Care, CA) across gestation, and willing to share data from this pregnancy with study staff.
What this trial measures
- Percent Time in Target RangeAssessed every 2 weeks from 4 weeks pre-conception to 6 months post partum
Percentage of time blood glucose was 70mg/dL and 180mg/dL as per CGM